Tsuyoshi Yanagimachi
Hirosaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Gastric Emptying Delay with Pre-Meal Administration of Metformin and Anagliptin in Type 2 Diabetes: Effects on Postprandial Glucose and Triglyceride Levels in a Two-Case Report.
Journal: The American journal of case reports
Published: October 15, 2025
miR-494 Deletion Improves Glucose Metabolism Independently of Obesity in Mice.
Journal: Diabetes
Published: April 09, 2025
O-linked N-acetylglucosamine modification is essential for physiological adipose expansion induced by high-fat feeding.
Journal: American journal of physiology. Endocrinology and metabolism
Published: May 24, 2023
Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial.
Journal: Diabetes research and clinical practice
Published: December 15, 2021
Glycaemia and body weight are regulated by sodium-glucose cotransporter 1 (SGLT1) expression via O-GlcNAcylation in the intestine.
Journal: Molecular metabolism
Published: December 02, 2021
Acromegaly Cases Exhibiting Increased Growth Hormone Levels during Oral Glucose Loading with Preadministration of Dipeptidyl Peptidase-4 Inhibitor.
Journal: Internal medicine (Tokyo, Japan)
Published: August 02, 2021
A Low-Carbohydrate Diet Improves Glucose Metabolism in Lean Insulinopenic Akita Mice Along With Sodium-Glucose Cotransporter 2 Inhibitor.
Journal: Frontiers in endocrinology
Published: September 01, 2020
Establishment of novel specific assay for short-form glucose-dependent insulinotropic polypeptide and evaluation of its secretion in nondiabetic subjects.
Journal: Physiological reports
Published: February 24, 2020
Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes.
Journal: Frontiers in endocrinology
Published: December 06, 2019
Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test.
Journal: BMC endocrine disorders
Published: July 16, 2019
Last Updated: 09/26/2026